Stifel Downgrades Medtronic: Growth Delays Impact Outlook
Stifel downgrades Medtronic to 'Hold' due to slow growth in key initiatives like HUGO system, affecting market competitiveness.
- Latest
- Trending
Stifel downgrades Medtronic to 'Hold' due to slow growth in key initiatives like HUGO system, affecting market competitiveness.
Dividend payers tend to outperform non-payers, making them a good choice for investors. Here are three stocks to consider for ...
Orchestra BioMed Holdings, Inc. financial report: Stock closed at $5.00, 52-week range $4.26-$23.39, market cap $188.013M. No dividends. Latest data ...
U.S. stock and bond markets will be closed for Presidents Day, causing a delay in trading. A busy week of ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.